Article
The CHIP–LMO7–BAG5 complex controls tau clearance and yields repurposed and newly designed therapeutic candidates for Alzheimer’s disease
2026-06-29
Abstract excerpt
Through cross-species genetic screens, we identified LMO7 as a regulator of tau levels in vivo . LMO7 bridges the E3 ligase CHIP and its inhibitory cochaperone BAG5, suppressing CHIP’s ligase activity and limiting tau ubiquitination and degradation. Adult LMO7 knockdown enhances CHIP activity, reduces total and phosphorylated tau, attenuates gliosis, and rescues memory deficits in tauopathy mice. Guided by AlphaF...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 129d9001-d45c-5c35-8708-d5dc55aaf7a5
- DOI
- 10.64898/2026.06.26.734369
